The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
Authors
Keywords
Cannabidiol, CBD, Cannabinoids, Schizophrenia, Psychosis, Cognition, Memory, Attention
Journal
PSYCHOPHARMACOLOGY
Volume 235, Issue 7, Pages 1923-1932
Publisher
Springer Nature
Online
2018-04-05
DOI
10.1007/s00213-018-4885-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Molecular Targets of Cannabidiol in Neurological Disorders
- (2015) Clementino Ibeas Bih et al. Neurotherapeutics
- Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol
- (2015) Felipe V. Gomes et al. SCHIZOPHRENIA RESEARCH
- Going up in Smoke? A Review of nAChRs-based Treatment Strategies for Improving Cognition in Schizophrenia
- (2014) Douglas Boggs et al. CURRENT PHARMACEUTICAL DESIGN
- MODULATION OF THE ENDOCANNABINOID SYSTEM AS A POTENTIAL NEW TARGET IN THE TREATMENT OF SCHIZOPHRENIA
- (2014) F. Markus Leweke et al. SCHIZOPHRENIA RESEARCH
- The Endocannabinoid System and the Brain
- (2012) Raphael Mechoulam et al. Annual Review of Psychology
- Feasibility, Safety and Efficacy of the Combination of D-Serine and Computerized Cognitive Retraining in Schizophrenia: An International Collaborative Pilot Study
- (2012) Deepak C D'Souza et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits
- (2011) Manoranjan S. D’Souza et al. NEUROPHARMACOLOGY
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- (2011) Elen V. Fagherazzi et al. PSYCHOPHARMACOLOGY
- Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation
- (2010) I Magen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
- (2010) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Discovery of 4-(5-Methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a Novel α7 Nicotinic Acetylcholine Receptor Agonist for the Treatment of Cognitive Disorders in Schizophrenia: Synthesis, SAR Development, and in Vivo Efficacy in Cognition Models
- (2010) Christopher J. O’Donnell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)
- (2010) Jaime E. C. Hallak et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample
- (2010) M. Yucel et al. SCHIZOPHRENIA BULLETIN
- Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis
- (2009) Dagmar Koethe et al. BRITISH JOURNAL OF PSYCHIATRY
- Cannabidiol: A Promising Drug for Neurodegenerative Disorders?
- (2009) Teresa Iuvone et al. CNS Neuroscience & Therapeutics
- Treating the Cognitive Deficits of Schizophrenia with Alpha4Beta2 Neuronal Nicotinic Receptor Agonists
- (2009) Richard Radek et al. CURRENT PHARMACEUTICAL DESIGN
- AC-260584, an orally bioavailable M1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model
- (2009) Stefania Risso Bradley et al. NEUROPHARMACOLOGY
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity
- (2008) Keith H. Nuechterlein et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders
- (2008) Caterina Scuderi et al. PHYTOTHERAPY RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now